Targeting the ANGPTL4/NRP1/ABL1/RAD51 axis reverses cisplatin resistance by impairing DNA damage repair in head and neck cancer - Emmanuel B. Asiedu; Ajay Kumar; Alexander Choi; Derek Osorio Luciano; Kevin Lo; Deepti Sharma; Tao Ma; Feyruz Rassool; Akrit Sodhi; Silvia Montaner (Proceedings of the National Academy of Sciences, 2026)